Stefano Cascinu

55PUBLICATIONS
157CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer geneticsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Aug 12, 2026
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting.

|Jul 29, 2026
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab.

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Oct 17, 2025
Durvalumab plus cisplatin and gemcitabine in advanced biliary tract cancer: can we do it better?

Margherita Rimini, Andrea Casadei-Gardini

|Sep 06, 2025
Letter Re: Reflections on the MAGIC-D Prognostic Model in Advanced Biliary Tract Cancer.

Mara Persano, Margherita Rimini, Lorenzo Fornaro

|Jun 26, 2025
D-lactate and glycerol as potential biomarkers of sorafenib activity in hepatocellular carcinoma.

Silvia Pedretti, Francesca Palermo, Miriana Braghin

Pageof 10

Frequent Collaborators

8 joint publications

Giorgia Marisi

8 joint publications

Margherita Rimini

6 joint publications

Caterina Vivaldi

5 joint publications

Ilario Giovanni Rapposelli